Maintenance of remission with leflunomide in Wegener's granulomatosis.
D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects / Q000627:therapeutic use*; D000077339:Leflunomide; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use*; D012008:Recurrence; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007555:Isoxazoles; D011239:Prednisolone; D000077339:Leflunomide